Explore more publications!

Healthy Living Maine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.

Press releases published on April 7, 2026

Solid Biosciences to Participate at Upcoming Investor Conferences
Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
Route 92 Medical Announces $50 Million Growth Financing
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Liquidia Corporation to Participate in Upcoming Investor Conferences
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions